REFERENCES
Duke SO, Lydon J, Becerril JS, et al (1991) Protoporphyrin oxidase inhibited herbicides. Weed Science 39: 465–467.
Kappas A, Sassa S, Galbraith R, Nordmann Y (1995) The porphyrias. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 2103–2159.
Kenji A, Takashi H (1987) Determination of coproporphyrins I and III in urine by highperformance liquid chromatography. Jpn J Clin Chem 16: 33–37.
Krijt J, Maruna P, Stranska P, Vokurka M (1996) Experimental variegate porphyria-porphyrin accumulation in peripheral nerves. J Inher Metab Dis 19 (supplement 1): 17.
Laine J, Salo MK, Krogerus L, Kärkkäinen J, Wahlroos O, Holmberg C (1995) The nephropathy of type I tyrosinemia after liver transplantation. Pediatr Res 37: 640–645.
Lindstedt S, Holme E, Lock EA, Hjalmarsson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340: 813–817.
Mitchell GA, Lambert M, Tanguay RM (1995) Hypertyrosinemia. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1077–1106.
Wright DJ, Lim CK (1983) Simultaneous determination of hydroxymethylbilane synthase and proporphyrinogen III synthase in erythrocytes by high-performance liquid chromatography. Biochem J 213: 85–88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Depetris-Boldini, C., Galetto, R., Videla, M.P. et al. Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: Relevant changes with NTBC treatment. J Inherit Metab Dis 22, 227–230 (1999). https://doi.org/10.1023/A:1005597029615
Issue Date:
DOI: https://doi.org/10.1023/A:1005597029615